Supply Chain | September 27, 2023
Cipla launches drone delivery of critical medicines in Himachal Pradesh
Commenced operations in flood-affected Himachal Pradesh
Commenced operations in flood-affected Himachal Pradesh
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
CiplaMed 2.0 leverages advanced analytics and automation
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Cipla has a robust governance model focused on sustainability
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Cipla has received 8 inspectional observations in Form 483
Subscribe To Our Newsletter & Stay Updated
